login

Commentary

Journal of Pain and Symptom ManagementPublished 1 August 1999Open access
David Casarett
Citations10
SJR quartileQ1
SJR score1.21
SNIP1.42
View PDF

TL;DR

This case highlights several challenging and emotionally laden issues about the growing field of end-of-life research and Dr. R's pointed questions to the trial’s PI suggest two issues in particular that deserve their attention, and the authors can begin to appreciate that ethics and science are inextricably intertwined in end- of- life research.

Abstract

This case highlights several challenging and emotionally laden issues about the growing field of end-of-life research. Dr. R's pointed questions to the trial's PI suggest two issues in particular that deserve our attention. First, we ought to consider whether end-of-life research is as ethically dubious as Dr. R suggests. Second, we should take a step back and consider Dr. R's second question about the ethics of the trial's exclusion criteria. The first question is an ethical one, but the second has both ethical and scientific aspects. By examining each of these questions in turn, we will get a more complete picture of the ethical contours of this case, and we can begin to appreciate that ethics and science are inextricably intertwined in end-of-life research.

Keywords

MedicineHealth Professions